|

Anti-VEGF Monoclonal Antibody Clinical Trials

1 actively recruiting trial across 1 location

Also known as: MoAb VEGF, Monoclonal Antibody Anti-VEGF

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute (NCI)1

Indications

  • Recurrent Platinum-Sensitive Primary Peritoneal High Grade Serous Adenocarcinoma1
  • Recurrent Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma1
  • Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma1
  • Recurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma1
  • Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.